Previous Close | 8.82 |
Open | 8.88 |
Bid | 0.00 x 1300 |
Ask | 0.00 x 1000 |
Day's Range | 8.76 - 9.08 |
52 Week Range | 8.17 - 10.41 |
Volume | |
Avg. Volume | 111,416 |
Market Cap | 421.42M |
Beta (5Y Monthly) | 1.13 |
PE Ratio (TTM) | 15.82 |
EPS (TTM) | 0.56 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for ZTR
Virtus Total Return Fund Inc. (NYSE: ZTR) previously announced the following monthly distribution on March 3, 2022:
Capacity to Process 100-Plus Samples per Week, with 1.6x Lower Limit of DetectionSOUTH SAN FRANCISCO, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today announced the launch of the Hyperion+™ Imaging System, the new standard in high-plex spatial imaging, providing lower limits of detection as well as improved sample capacity and time to results. The Hyperion™+ Imaging Syst
Virtus Total Return Fund Inc. (NYSE: ZTR) today announced the following monthly distributions: